The Use of Flow Cytometry to Assess a Novel Drug Efficacy in Multiple Sclerosis

Metabolic Brain Disease - United States
doi 10.1007/s11011-014-9634-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Use of Flow Cytometry to Study Sporeforming Bacteria

2015English

A10.13 Identification of Immunophenotypic Signatures in Peripheral Blood of Multiple Sclerosis Patients by Multiparametric Flow Cytometry

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

Ecological Validity of Methods to Assess Walking Ability in Multiple Sclerosis

2015English

Siponimod: A New Approved Oral Drug to Treat Multiple Sclerosis

NeuroPharmac Journal
2019English

Pnd130 - Measuring What Matters to People With Multiple Sclerosis and Preferences for Novel Methods to Assess Clinical Outcomes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Multi-Drug Use Among Patients With Multiple Sclerosis: A Cross-Sectional Study of Associations to Clinicodemographic Factors

Scientific Reports
Multidisciplinary
2019English

Optimizing Therapeutics in the Management of Patients With Multiple Sclerosis: A Review of Drug Efficacy, Dosing, and Mechanisms of Action

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Use of Flow Cytometry to Rapidly Optimize the Transfection of Animal Cells

BioTechniques
BiochemistryBiotechnologyGeneticsMolecular Biology
2000English

Use of Shakedown Maps to Assess Plastic Flow in Railway Curves

Proceedings of the Institution of Mechanical Engineers, Part F: Journal of Rail and Rapid Transit
Mechanical Engineering
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy